Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology (Q3078865): Difference between revisions

From MaRDI portal
Created claim: Wikidata QID (P12): Q40669546, #quickstatements; #temporary_batch_1711234560214
ReferenceBot (talk | contribs)
Changed an Item
 
Property / cites work
 
Property / cites work: Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities / rank
 
Normal rank
Property / cites work
 
Property / cites work: One-Sample Multiple Testing Procedure for Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bayesian Monitoring of Event Rates with Censored Data / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory / rank
 
Normal rank
Property / cites work
 
Property / cites work: Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes / rank
 
Normal rank
Property / cites work
 
Property / cites work: Practical Bayesian Guidelines for Phase IIB Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: An Optimal Design for Screening Trials / rank
 
Normal rank

Latest revision as of 19:19, 3 July 2024

scientific article
Language Label Description Also known as
English
Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology
scientific article

    Statements

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references